[Skip to Content]
[Skip to Content Landing]
Views 260
Citations 0
Comment & Response
February 20, 2018

Authorship Credit for Large Clinical Trials—Reply

Author Affiliations
  • 1First Department of Intensive Care Medicine, University of Athens Medical School, Athens, Greece
JAMA. 2018;319(7):723-724. doi:10.1001/jama.2017.20943

In Reply Drs Wilkinson and Sanacora propose broader distribution of authorship credit to augment involvement of academic researchers in randomized clinical trials (RCTs) and boost the multicenter evaluation of “preventive, diagnostic, and therapeutic interventions.” Despite current stringent authorship guidelines, data suggest that the number of mainly industry-sponsored, multinational RCTs is increasing, as are the proportions of large RCTs recruiting patients in 3 or more to more than 10 nations and more than 1 continent.1-3 These data suggest expansion of international collaborative networks associated with well-designed research projects to provide high-quality published evidence on potentially beneficial interventions.1